What is Veracyte's other commercial liabilities?

Veracyte (VCYT) reported other commercial liabilities of $43.13M in Q1 2026.

How has Veracyte's other commercial liabilities changed year-over-year?

Veracyte's other commercial liabilities increased by 20.0% year-over-year, from $35.93M to $43.13M.

What is the long-term trend for Veracyte's other commercial liabilities?

Over 5 years (2020 to 2025), Veracyte's other commercial liabilities has grown at a 33.0% compound annual growth rate (CAGR), from $11.71M to $48.8M.

Veracyte VCYT Other Commercial Liabilities

Other Commercial Liabilities at other companies

Guardant HealthGH

——

RevvityRVTY

——

Labcorp HoldingsLH

——

Idexx LaboratoriesIDXX

——

DanaherDHR

——

Adaptive BiotechnologiesADPT

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's other commercial liabilities?: Veracyte (VCYT) reported other commercial liabilities of $43.13M in Q1 2026.
How has Veracyte's other commercial liabilities changed year-over-year?: Veracyte's other commercial liabilities increased by 20.0% year-over-year, from $35.93M to $43.13M.
What is the long-term trend for Veracyte's other commercial liabilities?: Over 5 years (2020 to 2025), Veracyte's other commercial liabilities has grown at a 33.0% compound annual growth rate (CAGR), from $11.71M to $48.8M.